✕
← Today in NEWSDASH.LIVE
An experimental COPD drug from AstraZeneca could prove competitive with existing treatments, and have a slice of the market to itself.
3 outlets
·
Health & Medicine
1 left · 0 center · 1 right
How each outlet headlined it
STAT News
An experimental COPD drug from AstraZeneca could prove competitive with existing treatments, and have a slice of the market to itself.
CNBC
left
AstraZeneca's COPD drug scores two late-stage trial wins as full data boosts blockbuster hopes
The Wall Street Journal
right
AstraZeneca said its new drug for COPD showed benefits across a broad patient population in late-stage clinical trials, boosting a medicine the company expects to generate multibillion-dollar sales. on.wsj.com/4cyZ0y4
